Affinage

RIPPLY3

Protein ripply3 · UniProt P57055

Length
190 aa
Mass
20.4 kDa
Annotated
2026-06-10
10 papers in source corpus 9 papers cited in narrative 9 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

RIPPLY3 (DSCR6) is a transcriptional co-repressor that restricts target gene expression during pharyngeal arch, pre-placodal ectoderm, and cardiac outflow tract development by directly binding TBX1 and converting it from a transcriptional activator into a repressor (PMID:21177346, PMID:22354841). Through this switch, RIPPLY3 limits TBX1-driven expression of targets such as Pax9 and Fgf8; its loss derepresses Pax9 and causes hypotrophy of the caudal pharyngeal apparatus, ectopic thymus and parathyroid, and cardiovascular malformations, while in the pre-placodal ectoderm context TBX1 instead promotes Fgf8 when RIPPLY3 is absent (PMID:21177346, PMID:22354841). The RIPPLY3–TBX1 physical interaction is functionally essential: a p.T52S missense variant that weakens binding impairs repression of TBX1 activity (PMID:30241482). RIPPLY3 expression is positioned downstream of retinoic acid signaling — it is induced by RAR signaling, spatially restricted by RA to control posterior pharyngeal arch development, and epigenetically repressed by HDAC1 at RA response elements, with ectopic ripply3 in second heart field progenitors being sufficient to suppress ventricular cardiomyocyte development upstream of Tbx1 (PMID:22354841, PMID:31091225, PMID:33452727). Beyond transcriptional control, RIPPLY3 accumulates in focal adhesions and promotes their maturation, enhancing extracellular matrix–cell connection to resist mechanical stress during endodermal epithelial bending (PMID:29471585), and in Xenopus it binds the C-terminal region of Stat3 to antagonize Stat3 transcriptional and ventralizing activity by interfering with Stat3 lysine methylation (PMID:31996376). Dosage sensitivity is biologically consequential: Ripply3 overdosage in Down syndrome mouse models downregulates Tbx1 and causes midface shortening via reduced branchial arch cell proliferation (PMID:40982554).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2011 High

    Established RIPPLY3 as a negative regulator of TBX1, answering whether TBX1 activity is actively restrained during pharyngeal development.

    Evidence In vitro luciferase repression assays plus Ripply3 knockout mouse with Pax9 expression analysis

    PMID:21177346

    Open questions at the time
    • Did not resolve the structural basis of the RIPPLY3–TBX1 interaction
    • Did not establish how RIPPLY3 expression itself is controlled
  2. 2012 High

    Defined RIPPLY3 as a RAR-inducible molecular switch that converts TBX1 from activator to repressor, explaining context-dependent TBX1 output on Fgf8.

    Evidence Xenopus gain/loss-of-function with RAR manipulation and Tbx1/Ripply3 epistasis on Fgf8

    PMID:22354841

    Open questions at the time
    • Did not define the biochemical mechanism converting TBX1 from activator to repressor
    • Did not map the RAR-responsive cis-elements driving Ripply3
  3. 2014 Low

    Extended RIPPLY3 function beyond pharyngeal patterning to endocrine pancreas, where it restrains progenitor proliferation downstream of Insm1.

    Evidence Loss-of-function analysis in Insm1-reporter mouse pancreatic endocrine cells with proliferation assays

    PMID:25053427

    Open questions at the time
    • Described briefly within a broader Insm1 study with no Ripply3-specific mechanism
    • No molecular target identified in this context
    • Whether TBX1 is involved is untested
  4. 2018 Medium

    Revealed a non-transcriptional role: RIPPLY3 localizes to focal adhesions and promotes their maturation to maintain epithelial integrity under mechanical stress.

    Evidence Immunofluorescence localization in cultured cells and Ripply3 KO mouse endodermal epithelium with Integrin β1 activation readout

    PMID:29471585

    Open questions at the time
    • Direct molecular partners at focal adhesions not identified
    • Single lab; no biochemical mechanism linking RIPPLY3 to Integrin β1 activation
    • Relationship between this role and its transcriptional function unresolved
  5. 2018 Medium

    Demonstrated the RIPPLY3–TBX1 physical interaction is required for repression, by linking a binding-weakening variant to impaired function.

    Evidence Co-IP and luciferase repression assays with p.T52S mutagenesis

    PMID:30241482

    Open questions at the time
    • Interaction interface not mapped at residue resolution beyond the variant
    • In vivo consequence of the variant not tested
    • Single lab
  6. 2019 High

    Placed ripply3 in the HDAC1/RA regulatory hierarchy, showing epigenetic repression at RAREs controls its dosage and that its excess suppresses ventricular cardiomyocyte development upstream of Tbx1.

    Evidence Zebrafish hdac1 mutant, ripply3 overexpression, ripply3/tbx1 double knockdown rescue, and chromatin analysis of RAREs

    PMID:31091225

    Open questions at the time
    • Direct chromatin binding of HDAC1 to the ripply3 locus not biochemically resolved
    • Mechanism by which ripply3 dosage tunes Tbx1 output in SHF not detailed
  7. 2020 Medium

    Uncovered a TBX1-independent transcriptional role, showing RIPPLY3 binds Stat3 and blocks its lysine methylation to antagonize ventralizing activity.

    Evidence Co-IP of Stat3–DSCR6, transcriptional activity assays, Xenopus gain/loss-of-function, and epistasis with Ezh2/lysine methylation

    PMID:31996376

    Open questions at the time
    • Mechanism by which RIPPLY3 binding interferes with Stat3 methylation not structurally defined
    • Single lab, Xenopus only
    • Whether this role operates in mammalian development untested
  8. 2021 Medium

    Showed RA signaling spatially restricts the Ripply3 expression domain to pattern posterior pharyngeal arch development.

    Evidence RAR antagonism (BMS493), Raldh2 KO mouse, and a 6 kb Ripply3 promoter EGFP reporter with in situ analysis

    PMID:33452727

    Open questions at the time
    • Specific RA-responsive elements within the promoter not delineated
    • Single lab
  9. 2025 Medium

    Connected RIPPLY3 dosage to craniofacial disease, showing overdosage downregulates Tbx1 and causes midface shortening through reduced branchial arch proliferation in Down syndrome models.

    Evidence Down syndrome segmental duplication mouse models with craniofacial morphometry, proliferation assays, and Tbx1 expression analysis

    PMID:40982554

    Open questions at the time
    • Mechanism linking Ripply3 overdosage to Tbx1 downregulation not fully resolved
    • Single lab
    • Contribution relative to other DS-region genes unquantified

Open questions

Synthesis pass · forward-looking unresolved questions
  • How RIPPLY3 mechanistically reconciles its transcriptional co-repressor function, its focal adhesion role, and its Stat3 antagonism within a single protein remains unresolved.
  • No structural model of RIPPLY3 or its interaction surfaces
  • Direct biochemical mechanism of TBX1 activator-to-repressor conversion unknown
  • Whether the focal adhesion and Stat3 roles operate in the same cells as the TBX1 role is untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 4 GO:0098772 molecular function regulator activity 3
Localization
GO:0005634 nucleus 1 GO:0005856 cytoskeleton 1
Pathway
R-HSA-1266738 Developmental Biology 3 R-HSA-74160 Gene expression (Transcription) 3
Partners
STAT3TBX1

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2011 RIPPLY3 suppresses transcriptional activation by TBX1 in vitro, as shown by luciferase assays. Ripply3-deficient mice exhibit hypotrophy of the caudal pharyngeal apparatus, ectopic thymus and parathyroid gland formation, and cardiovascular malformations. RIPPLY3 represses TBX1-induced expression of Pax9, and Ripply3-deficient embryos show upregulated Pax9 expression, placing RIPPLY3 as a negative regulator of TBX1 activity in pharyngeal development. Luciferase transcriptional repression assays in vitro; Ripply3 knockout mouse with pharyngeal and cardiovascular phenotyping; Pax9 expression analysis in mutant embryos Development (Cambridge, England) High 21177346
2012 RIPPLY3 is induced by retinoic acid receptor (RAR) signaling and, in the presence of RIPPLY3, TBX1 acts as a transcriptional repressor to restrict positional expression of Fgf8 during pre-placodal ectoderm (PPE) formation. In the absence of RIPPLY3, TBX1 instead promotes Fgf8 expression required for PPE formation, establishing RIPPLY3 as a RAR-inducible switch that converts TBX1 from activator to repressor. Xenopus gain- and loss-of-function experiments; RAR signaling manipulation; Fgf8 expression analysis; epistasis between Ripply3 and Tbx1 Development (Cambridge, England) High 22354841
2018 RIPPLY3 protein accumulates preferentially in focal adhesions in cultured cells and promotes maturation of focal adhesions. In Ripply3-deficient mouse embryos, the activated form of Integrin β1 (normally localized basally in endodermal epithelial cells) is not persistently observed, and the continuous monolayer of the endodermal epithelium is not maintained posterior to the 2nd pharyngeal pouch, indicating RIPPLY3 enhances extracellular matrix–cell connection to resist mechanical stress during epithelial bending. Immunofluorescence subcellular localization in cultured cells; Ripply3 KO mouse with endodermal epithelium and Integrin β1 phenotyping; cell proliferation and apoptosis assays (negative results for those readouts) Development, growth & differentiation Medium 29471585
2019 In zebrafish, HDAC1 directly represses ripply3 expression by maintaining repressive epigenetic marks at RA response elements (RAREs) associated with RA receptors. Loss of Hdac1 leads to ectopic ripply3 expression in nkx2.5+ second heart field (SHF) progenitors. Excess ripply3 is sufficient to repress ventricular cardiomyocyte (VC) development, and genetic depletion of both Ripply3 and Tbx1 in hdac1 mutants partially restores VC number, placing ripply3 downstream of Hdac1/RA signaling and upstream of Tbx1 in SHF development. Zebrafish hdac1 mutant (crg allele); cyp26 mutant analysis; ripply3 overexpression; ripply3/tbx1 double knockdown; chromatin analysis of RAREs (epigenetic signature); VC quantification PLoS genetics High 31091225
2020 In Xenopus, DSCR6 (RIPPLY3) binds to the C-terminal region of Stat3 and antagonizes Stat3 transcriptional and ventralizing activities by interfering with Stat3 lysine methylation. DSCR6 specifies dorsal mesoderm fate by counteracting the ventralizing (Ezh2-dependent Stat3 methylation/activation) activity, and inhibition of either Ezh2 phosphorylation or Stat3 lysine methylation compensated for the absence of DSCR6 function. Co-immunoprecipitation (Stat3–DSCR6 interaction); transcriptional activity assays; loss-of-function and gain-of-function in Xenopus embryos; epistasis with Ezh2; lysine methylation assays The Journal of biological chemistry Medium 31996376
2018 A missense variant p.T52S in RIPPLY3 reduces the physical interaction of RIPPLY3 with TBX1 (by co-immunoprecipitation) and alters inhibition of TBX1 transcriptional activity in vitro (luciferase assay), demonstrating that the RIPPLY3–TBX1 direct protein interaction is functionally required for TBX1 repression. Co-immunoprecipitation of RIPPLY3 variants with TBX1; luciferase transcriptional repression assay; Western blot and immunofluorescence of variant proteins Journal of translational medicine Medium 30241482
2014 Ripply3, an Insm1-regulated gene enriched in the Pdx1-high endocrine progenitor cell population, negatively regulates the proliferation of early pancreatic endocrine cells, as shown by analysis of Ripply3 function in developing pancreatic endocrine cells. Loss-of-function analysis of Ripply3 in pancreatic endocrine cell development; Insm1(GFPCre) reporter mouse; cell proliferation assays Development (Cambridge, England) Low 25053427
2021 Retinoic acid (RA) signaling regulates the spatio-temporal expression of Ripply3 in mouse pharyngeal arch (PA) development. Inhibition of RA signaling (BMS493 or Raldh2 KO) reduces or redistributes Ripply3 expression, whereas a 6 kb Ripply3 promoter fragment EGFP reporter recapitulates endogenous expression but shows posterior expansion in RA-deficient embryos, indicating RA signaling restricts the Ripply3 expression domain to control posterior PA development. Pharmacological RAR antagonism (BMS493); Raldh2 KO mouse; EGFP reporter driven by 6 kb Ripply3 promoter fragment; in situ hybridization of Ripply3 expression Developmental dynamics Medium 33452727
2025 Overdosage of Ripply3 in Down syndrome mouse models causes midface shortening through downregulation of Tbx1, occurring during branchial arch development via a reduction in cell proliferation. DS segmental duplication mouse models; craniofacial morphometry; cell proliferation assays in branchial arches; Tbx1 expression analysis PLoS genetics Medium 40982554

Source papers

Stage 0 corpus · 10 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2014 Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3. Development (Cambridge, England) 58 25053427
2011 Ripply3, a Tbx1 repressor, is required for development of the pharyngeal apparatus and its derivatives in mice. Development (Cambridge, England) 47 21177346
2012 RIPPLY3 is a retinoic acid-inducible repressor required for setting the borders of the pre-placodal ectoderm. Development (Cambridge, England) 43 22354841
2000 Isolation of two novel genes, DSCR5 and DSCR6, from Down syndrome critical region on human chromosome 21q22.2. Biochemical and biophysical research communications 26 10814524
2019 HDAC1-mediated repression of the retinoic acid-responsive gene ripply3 promotes second heart field development. PLoS genetics 21 31091225
2018 Ripply3 is required for the maintenance of epithelial sheets in the morphogenesis of pharyngeal pouches. Development, growth & differentiation 4 29471585
2021 Effect of retinoic acid signaling on Ripply3 expression and pharyngeal arch morphogenesis in mouse embryos. Developmental dynamics : an official publication of the American Association of Anatomists 3 33452727
2020 The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during Xenopus development. The Journal of biological chemistry 3 31996376
2018 A loss-of-function mutation p.T52S in RIPPLY3 is a potential predisposing genetic risk factor for Chinese Han conotruncal heart defect patients without the 22q11.2 deletion/duplication. Journal of translational medicine 3 30241482
2025 Ripply3 overdosage induces mid-face shortening through Tbx1 downregulation in Down syndrome models. PLoS genetics 1 40982554

Missed literature

Know a paper Affinage missed for RIPPLY3? Flag it for the maintainers and the community.

No submissions yet.